Guangdong Huanan Pharmaceutical Group Co. Ltd.

Radiation proctitis is inflammation and harm to the lower parts of the colon after X-ray or radiation treatment. Radiation treatment to the pelvis is critical in the treatment of pelvic malignancies, because it damage the DNA of the cancer cells and a result the proliferation stops. Initially, low dose radiation therapy show no benefit in the treatment of rectal malignancy, as it showing resistance against the cancer cells. But, later it was found that higher doses were essential to overcome the resistance to treat cancers. However, higher doses of radiation lead to organ damage. Presently, proctitis is the most common complication of radiation treatment using high doses, particularly after treatment for prostate tumor. Despite advances made in radiation science, several study reports show that 75% of patients suffer from acute radiation proctitis. Read Report Overview - Based on treatment type, the global radiation proctitis treatment market can be segmented into non-invasive and invasive. The non-invasive segment can be classified into nonsterodial anti-inflammatory drugs, sucralfate, short chain fatty acids, hyperbaric oxygen, and antioxidants. The sucralfate drugs sub-segment is likely to expand at a rapid pace during the forecast period, as sucralfate agents such as pentosan polysulfate contain high sulfated polyanionic disaccharide compound that stimulates epithelial healing and forms a coating that helps to heal more quickly. In terms of distribution channel, the global radiation proctitis treatment market can be bifurcated into hospital pharmacies and medical stores. The hospital pharmacies segment is likely to expand at a significant pace during the forecast period, as radiation proctitis treatment is mostly performed in hospitals and patients feel convenient to purchase drugs through hospital pharmacies. Request Brochure of Report - Rise in prevalence of prostate, rectal, and cervical cancers is a major factor fueling the growth of the global radiation proctitis treatment market. Moreover, increase in adoption of radiation therapy to treat cancer is projected to drive the radiation proctitis treatment market during the forecast period. However, adverse reactions of non-invasive drugs such as transient nausea and occasional vomiting are likely to hamper the radiation proctitis treatment market in the next few years. Request for Analysis of COVID-19 Impact on Radiation Proctitis Treatment Market- In terms of region, the global radiation proctitis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global radiation proctitis treatment market. The region is projected to account for a significant share of the global market during the forecast period, due to rise in prevalence of rectal cancer in the region. According to the American Cancer Society in 2014, over 94,890 women will be diagnosed with gynecological cancer in the U.S. In Europe, incidence of prostate cancer is increasing among the geriatric population. This is projected to propel the radiation proctitis treatment market in the region during the forecast period. Increase in radiation exposure to treat various disease such as cancer is likely to propel the radiation proctitis treatment market in Asia Pacific during the forecast period. Prevalence of diseases that require frequent X-ray and radiation therapy is increasing in Central Africa. This is expected to augment the radiation proctitis treatment market in Middle East & Africa during the forecast period. Pre Book Radiation Proctitis Treatment Market Report - Key players operating in the global radiation proctitis treatment market are Chugai Pharmaceutical Co Ltd., GlaxoSmithKline plc, Nanjing Pharmaceutical Factory Co., Ltd., Allergan plc, Reckitt & Benckiser, Sun Pharmaceutical Industries Ltd., Northeast Pharmaceutical, Huanan Pharma, and Dr. Reddy Laboratories Ltd., among others. More Trending Reports by Transparency Market Research: Rehabilitation Products Market The home-based rehabilitation has emerged as one of the supportive programs during the coronavirus pandemic, which is reducing the burden on healthcare professionals in hospitals. Companies in the home rehabilitation products & services market are expanding their supply chains through eCommerce and online pharmacies to keep economies running during the pandemic. Medical Sensors Market Medical sensors are electronic devices integrated in medical devices, equipment, and probes. Sensor signal enables accurate diagnosis, control over activities, and treatment. Medical sensors are widely being implemented for the purpose of diseases diagnosis and other health associated application, including remote patient monitoring. Pelvic Floor Electrical Stimulation Devices Market Over the past few decades, technological advancements coupled with research and development activities have played an imperative role in shaping the healthcare sector. Within the healthcare sector, a range of new cutting-edge electrical devices has entered the market to treat a broad spectrum of medical diseases and conditions. About Us Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website:

High reliance on chemotherapy and other radiation based cancer treatment approaches are accentuating prevalence of radiation proctitis, prompting patients to opt for advanced therapeutic approaches Fact.MR, Rockville MD: Award winning market research company Fact.MR’s ongoing study on the global radiation proctitis treatment market anticipates a positive outlook for FY 2021-22, underpinned by increasing emphasis on radiation therapy to treat pelvic malignancies across key geographies. Despite a blip experienced during the peak of the pandemic crisis, the market is slated to emerge strong, posting substantial gains in forthcoming years. According to popular studies, likelihood of chronic proctitis as a side effect amongst radiotherapy patients is about 5%. Furthermore, an extensive study published by the European Organization for Research and Treatment of Cancer (EORTC) and the Radiotherapy Oncology Group (RTOG) reports a 3-40% prevalence rate of radiation proctitis amongst patients who avail external beam radiation. However, a series of intensity-modulated radiation therapy (IMRT) trials report that occurrences vary from 2-10%, and that of particle radiotherapy at less than 1%. Manufacturers are expected to discover fresh revenue pools especially across the rectal cancer segment, as one of the most common symptoms of radiation proctitis is rectal bleeding. Consequently, healthcare providers have been concentrating on endoscopic approaches to stem this problem. An effective approach has been implementation of medical lasers which help coagulate or ablate the tissue. An NCBI study concluded that patients suffering from radiation proctitis who have received laser treatment experienced a major improvement. Daily rectal bleeding rates declined from 85% to 11%, which was highly statistically significant. “While radiation therapy has significantly improved cancer patient survival rates in the recent past, high reliance on the same have heightened concerns regarding possible long-term impacts on human health. This has only served to underscore the importance of radiation proctitis, providing a wide platform for key manufacturers to offer highly advanced treatment approaches,” remarks the Fact.MR analyst. Request a report sample to gain comprehensive insights at Key Takeaways from Fact.MR’s Radiation Proctitis Treatment Market Study By indication, acute radiation proctitis treatment to remain the primary application area Oral radiation proctitis treatment to remain the most preferred therapy type through 2021 and beyond By type, non-invasive sucralfate drug treatment to capture significant attention By distribution channel, hospital pharmacies are expected to capture the majority share US to experience high radiation proctitis treatment, owing to high treatment seeking rates for colon and rectal cancers High prevalence rates of cervical cancers to stimulate treatment procedures across the UK Germany to open up new revenue ecosystems, attributed to high ovarian cancer treatment procedures Heightened expenditure on gynecological cancer treatment and research further growth prospects across India & China Radiation Proctitis Treatment Market- Prominent Drivers High prevalence rates of cervical, prostate and rectal cancers is augmenting treatment procedures for the same, heightening growth prospects Increased reliance on radiation therapy for better patient outcomes is likely to enhance advanced radiation proctitis treatment adoption Governments worldwide are providing increasing assistance with regards to research funding to develop new therapeutic approaches Radiation Proctitis Treatment Market- Key Restraints Inadequate awareness regarding the dangers of radiation proctitis is limiting adoption across several regions Sluggish healthcare infrastructure development in emerging economies renders it unaffordable for key healthcare institutions to invest in advanced radiation proctitis treatment options Discover more about the Radiation Proctitis Treatment market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on Competitive Landscape Chugai Pharmaceutical Co. Ltd., GlaxoSmithKline Plc, Dr. Reddy’s Laboratories Ltd., Allergan Plc, Northeast Pharmaceuticals, Reckitt & Benckiser, Guangdong Huanan Pharma, Sun Pharmaceutical Industries and Nanjing Pharmaceutical Factory Co. Ltd. are some prominent radiation proctitis treatment solutions providers profiled in Fact.MR’s extensive study. The aforementioned market players rely on a slew of expansion strategies, including offering new products, collaborating with healthcare research institutions, capacity expansion measures and strategic partnerships to enhance their market footprint across key regions. More Insights on the Radiation Proctitis Treatment Market Fact.MR, in its new offering, brings to fore an unbiased analysis of the global radiation proctitis treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period, 2021-2031. The study divulges compelling insights on the radiation proctitis treatment market based on indication (acute radiation proctitis treatment and chronic radiation proctitis treatment), therapy (oral therapy, rectal instillation therapy, thermal therapy and hyperbaric oxygen therapy), type (non-invasive and invasive), route of administration (oral and intravenous) and distribution channel (hospital pharmacies, drug stores, retail pharmacies and online pharmacies) across seven major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa). Request For No-Obligation Table Of Content Explore Fact.MR’s Coverage on the Healthcare Domain Olaparib API Market: Fact.MR’s ongoing research project on the olaparib API market delves into detailed observations regarding the prominent expansion prospects expected to present themselves throughout the forthcoming decade. The study incorporates an in-depth analysis of the prominent market drivers, restraints and opportunities, along with statistics on key segments’ scope across prominent geographies. Cough Systems Market: The global cough systems market is likely to escalate to new heights, amid rising prevalence of various respiratory disorders, according to an ongoing study on the market by Fact.MR. The report sheds light on prominent segments’ growth dynamics across highly lucrative regions, along with an in-depth competitive landscape for the forecast period 2021-2031. Byler Disease Market: Fact.MR’s incumbent study on the byler disease market brings to the fore important growth dynamics which are expected to shape future expansion trajectory for the decade until 2031. It provides an exhaustive analysis of the market’s key drivers, opportunities and limitations across prominent geographical locations and segments. About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner. Contact: US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E: sales@factmr.com Follow Us: LinkedIn | Twitter Market Intelligence Services: Marketngage.com Source: Fact.MR

Radiation proctitis is inflammation and harm to the lower parts of the colon after X-ray or radiation treatment. Radiation treatment to the pelvis is critical in the treatment of pelvic malignancies, because it damage the DNA of the cancer cells and a result the proliferation stops. Initially, low dose radiation therapy show no benefit in the treatment of rectal malignancy, as it showing resistance against the cancer cells. But, later it was found that higher doses were essential to overcome the resistance to treat cancers. However, higher doses of radiation lead to organ damage. Presently, proctitis is the most common complication of radiation treatment using high doses, particularly after treatment for prostate tumor. Despite advances made in radiation science, several study reports show that 75% of patients suffer from acute radiation proctitis. Read Report Overview - Based on treatment type, the global radiation proctitis treatment market can be segmented into non-invasive and invasive. The non-invasive segment can be classified into nonsterodial anti-inflammatory drugs, sucralfate, short chain fatty acids, hyperbaric oxygen, and antioxidants. The sucralfate drugs sub-segment is likely to expand at a rapid pace during the forecast period, as sucralfate agents such as pentosan polysulfate contain high sulfated polyanionic disaccharide compound that stimulates epithelial healing and forms a coating that helps to heal more quickly. In terms of distribution channel, the global radiation proctitis treatment market can be bifurcated into hospital pharmacies and medical stores. The hospital pharmacies segment is likely to expand at a significant pace during the forecast period, as radiation proctitis treatment is mostly performed in hospitals and patients feel convenient to purchase drugs through hospital pharmacies. Request Brochure of Report - Rise in prevalence of prostate, rectal, and cervical cancers is a major factor fueling the growth of the global radiation proctitis treatment market. Moreover, increase in adoption of radiation therapy to treat cancer is projected to drive the radiation proctitis treatment market during the forecast period. However, adverse reactions of non-invasive drugs such as transient nausea and occasional vomiting are likely to hamper the radiation proctitis treatment market in the next few years. Request for Analysis of COVID-19 Impact on Radiation Proctitis Treatment Market- In terms of region, the global radiation proctitis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global radiation proctitis treatment market. The region is projected to account for a significant share of the global market during the forecast period, due to rise in prevalence of rectal cancer in the region. According to the American Cancer Society in 2014, over 94,890 women will be diagnosed with gynecological cancer in the U.S. In Europe, incidence of prostate cancer is increasing among the geriatric population. This is projected to propel the radiation proctitis treatment market in the region during the forecast period. Increase in radiation exposure to treat various disease such as cancer is likely to propel the radiation proctitis treatment market in Asia Pacific during the forecast period. Prevalence of diseases that require frequent X-ray and radiation therapy is increasing in Central Africa. This is expected to augment the radiation proctitis treatment market in Middle East & Africa during the forecast period. Request for Custom Research - Key players operating in the global radiation proctitis treatment market are Chugai Pharmaceutical Co Ltd., GlaxoSmithKline plc, Nanjing Pharmaceutical Factory Co., Ltd., Allergan plc, Reckitt & Benckiser, Sun Pharmaceutical Industries Ltd., Northeast Pharmaceutical, Huanan Pharma, and Dr. Reddy Laboratories Ltd., among others. Pre Book Radiation Proctitis Treatment Market Report - About Us Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: